Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
California was already contending with a home insurance crisis due to unpredictable weather events. Then came this week’s fires.
England had a rude awakening this week, as the United Kingdom was transported back in time to one of the most tumultuous years in its history.
Defined outcome ETFs have long promised virtually risk-free investing, but also place significant caps on potential gains.